Seguimiento de las recomendaciones en prevención secundaria cerebrovascular en atención primaria

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Tamayo-Ojeda, Carmenca
• dc.contributor.author Parellada-Esquiusb, Neusca
• dc.contributor.author Salvador-González, Betlemca
• dc.contributor.author Oriol-Torón, Pilar Ángelesca
• dc.contributor.author Rodríguez-Garrido, M. Doloresca
• dc.contributor.author Muñoz-Segura, Doloresca
• dc.date.accessioned 2017-11-21T08:41:33Z
• dc.date.available 2017-11-21T08:41:33Z
• dc.date.issued 2017
• dc.description.abstract OBJECTIVE: Knowing compliance with secondary prevention recommendations of stroke in primary care and to identify factors associated with compliance. DESIGN: Multi-centre cross-sectional. SETTING: Health primary care centres in a metropolitan area (944,280 inhabitants). PARTICIPANTS: Patients aged 18years and over with ischemic brain disease diagnosis prior to 6months before the study. MAIN MEASUREMENTS: Clinical history records of demographic variables, risk factors and cardiovascular comorbidity, drugs, blood pressure values (BP), LDL-cholesterol and medical visits by doctor and nurses after the event. Good adherence was considered when BP <140/90 mmHg, LDL-cholesterol <100 mg/dL, smoking abstention and preventive drugs prescription (anti-platelet/anticoagulants, statins and angiotensin-converting-enzyme inhibitors/angiotensin-receptor-antagonists or diuretics) during the last 18months. RESULTS: A total of 21,976 patients, mean age 73.12 years (SD: 12.13), 48% women, 72.7% with stroke. Co-morbidity: hypertension 70.8%, dyslipidemia 55.1%, DM 30.9%, atrial fibrillation 14.1%, ischemic heart disease 13.5%, chronic renal failure 12.5%, heart failure 8.8%, peripheral arterial disease 6.2%, dementia 7.8%. No record was found for smoking in 3.7%, for BP in 3.5% and for LDL in 6.5%. Optimal control: abstention smoking in 3.7%, BP <140/90 in 65.7% and LDL <100 mg/dL in 41.0%. TREATMENT: 86.2% anti-platelet/anticoagulants, 61.3% statins and 61.8% angiotensin-converting-enzyme inhibitors, angiotensin-receptor-antagonists or diuretic. Registration and risk factors control was higher in 66-79years aged and lower in 18-40years aged. CONCLUSIONS: The implementation of clinical guidelines recommendations for stroke prevention in primary care must be improved, especially among younger population. Organizational changes and more active involvement by professionals and strategies against therapeutic inertia must be taken.
• dc.format.mimetype application/pdfca
• dc.identifier.citation Tamayo-Ojeda C, Parellada-Esquius N, Salvador-González B, Oriol-Torón PA, Rodríguez-Garrido MD, Muñoz-Segura D. Seguimiento de las recomendaciones en prevención secundaria cerebrovascular en atención primaria. Aten Primaria. 2017 Jun - Jul;49(6):351-358. DOI: 10.1016/j.aprim.2016.07.004
• dc.identifier.doi http://dx.doi.org/10.1016/j.aprim.2016.07.004
• dc.identifier.issn 0212-6567
• dc.identifier.uri http://hdl.handle.net/10230/33286
• dc.language.iso spa
• dc.publisher Elsevierca
• dc.relation.ispartof Atención Primaria. 2017 Jun - Jul;49(6):351-8
• dc.rights © 2016 Elsevier España, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/
• dc.subject.keyword Accidente cerebrovascular
• dc.subject.keyword Atención primaria
• dc.subject.keyword Cerebral infarction
• dc.subject.keyword Ictus
• dc.subject.keyword Prevención secundaria
• dc.subject.keyword Primary health care
• dc.subject.keyword Secondary prevention
• dc.subject.keyword Stroke
• dc.subject.other Malalties cerebrovasculars
• dc.subject.other Cervell -- Malalties
• dc.title Seguimiento de las recomendaciones en prevención secundaria cerebrovascular en atención primariaca
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion